Literature DB >> 11972631

Lack of evidence for aggregation-dependent enhancement of p56lck in the signal transduction upon major histocompatibility complex recognition by mature T cells.

Koji Eshima1, Harumi Suzuki, Nobukata Shinohara.   

Abstract

The kinase activity of lymphocyte-specific tyrosine kinase p56lck (Lck) upon physiological major histocompatibility complex (MHC) recognition by normal mature T cells was examined. Recognition of the target MHC molecules by T cells induced phosphorylation of the zeta-chain without obvious enhancement of the background Lck activity. There was no sign of enhancement of Lck through putative T-cell receptor (TCR)-independent class II MHC/CD4 interactions either. As has been reported, cross-linking of CD4 molecules by antibodies induced a marked enhancement of Lck activity. However, it did not have an immediate relevance to TCR-mediated signal transduction, as judged from the lack of detectable de novo phosphorylation of zeta-chain and the absence of functional responses of T cells. These results strongly favour the model in which TCR-mediated signal transduction does not involve aggregation-dependent enhancement of Lck, suggesting that the signal can be triggered simply by the recruitment of already active Lck with basal kinase activity through the formation of a TCR/MHC/CD4 ternary complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972631      PMCID: PMC1782695          DOI: 10.1046/j.1365-2567.2002.01392.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain.

Authors:  A C Chan; M Iwashima; C W Turck; A Weiss
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

Review 2.  The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation.

Authors:  C A Janeway
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

3.  Correlation between the V beta 4+ CD8+ T-cell population and the H-2d haplotype.

Authors:  K Tomonari; E Lovering; S Spencer
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Activators of protein kinase C induce dissociation of CD4, but not CD8, from p56lck.

Authors:  T R Hurley; K Luo; B M Sefton
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

5.  Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; L E Samelson; J B Bolen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

6.  Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site.

Authors:  K X Luo; B M Sefton
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes.

Authors:  G Legname; B Seddon; M Lovatt; P Tomlinson; N Sarner; M Tolaini; K Williams; T Norton; D Kioussis; R Zamoyska
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

8.  IA mutant functional antigen-presenting cell lines.

Authors:  L H Glimcher; T Hamano; R Asofsky; D H Sachs; M Pierres; L E Samelson; S O Sharrow; W E Paul
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2.

Authors:  S Danielian; R Fagard; A Alcover; O Acuto; S Fischer
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

10.  Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins.

Authors:  J A Punt; R T Kubo; T Saito; T H Finkel; S Kathiresan; K J Blank; Y Hashimoto
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.